Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 777.10
-15.40 (-1.94%)
Jun 1, 2026, 3:30 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 39.41 billion as of June 1, 2026. Its market cap has increased by 0.15% in one year.
Market Cap
39.41B
Enterprise Value
42.21B
Revenue
8.11B
Ranking
n/a
PE Ratio
191.88
Stock Price
777.10
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 39.41B, an increase of 5,318.84%. That is a compound annual growth rate of 104.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 40.19B | 4.42% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Strides Pharma Science | 102.48B |
| Sudeep Pharma | 83.82B |
| Akums Drugs and Pharmaceuticals | 80.30B |
| Sun Pharma Advanced Research Company | 68.83B |
| Aarti Pharmalabs | 57.41B |
| Innova Captab | 48.66B |
| RPG Life Sciences | 36.79B |
| Solara Active Pharma Sciences | 25.66B |